Daiichi Sankyo
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daiichi Sankyo and other ETFs, options, and stocks.About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.
CEOHiroyuki Okuzawa
CEOHiroyuki Okuzawa
Employees20,171
Employees20,171
HeadquartersTokyo, Tokyo
HeadquartersTokyo, Tokyo
Founded2005
Founded2005
Employees20,171
Employees20,171
DSNKY Key Statistics
Market cap34.77B
Market cap34.77B
Price-Earnings ratio20.21
Price-Earnings ratio20.21
Dividend yield1.30%
Dividend yield1.30%
Average volume93.52K
Average volume93.52K
High today$18.77
High today$18.77
Low today$18.53
Low today$18.53
Open price$18.59
Open price$18.59
Volume5.81K
Volume5.81K
52 Week high$27.50
52 Week high$27.50
52 Week low$14.98
52 Week low$14.98
DSNKY News
Investing.com 1d
Daiichi Sankyo and Merck withdraw lung cancer drug application - Investing.com...
Analyst ratings
76%
of 17 ratingsBuy
76.5%
Hold
23.5%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.